Inhaled corticosteroid dose comparison

Patients requiring oral corticosteroids should be weaned slowly from systemic corticosteroid use after transferring to ALVESCO. Prednisone reduction can be accomplished by reducing the daily prednisone dose by mg on a weekly basis during ALVESCO therapy [see DOSAGE AND ADMINISTRATION ]. Lung function (FEV 1 or AM PEFR), beta-agonist use, and asthma symptoms should be carefully monitored during withdrawal of oral corticosteroids. In addition to monitoring asthma signs and symptoms, patients should be observed for signs and symptoms of adrenal insufficiency, such as fatigue, lassitude , weakness, nausea and vomiting, and hypotension .

The most commonly reported side effects were: oral thrush , nausea , headache , and pain in the pharynx or larynx . More rarely reported side effects (occurring in <1% of patients during the clinical trial) include: tachycardia , palpitations , dry mouth , allergic reaction ( bronchospasm , dermatitis , hives ), pharyngitis , muscle spasms , tremor , dizziness , insomnia , nervousness , and hypertension . Patients experiencing an allergic reaction or increase in difficulty breathing while using this medication should immediately discontinue its use and contact their physician. [4]

Inhaled corticosteroid dose comparison

inhaled corticosteroid dose comparison

Media:

inhaled corticosteroid dose comparisoninhaled corticosteroid dose comparisoninhaled corticosteroid dose comparisoninhaled corticosteroid dose comparisoninhaled corticosteroid dose comparison

http://buy-steroids.org